The Role of Fibrocytes in Acute Lung Injury

Overview

The important character of acute lung injury (ALI) is alveolar capillary membrane damage caused by different diseases, such as sepsis, trauma and shock. One of the important pathological stages is the varying degrees of interstitial fibrosis and semi-permeable alveolar membrane fibrosis. It has been proved that CXCL12/SDF-1 (stromal cell-derived factor-1) induces fibrocyte migration, and promotes fibrosis progression. Study indicated that inhibition of TLR4 receptor signaling pathway improves fibrosis progression induced by ALI, however, the role of fibrocyte in ALI is still unclear. The fibrocytes was significantly increased in asthmatic patients with pulmonary fibrosis, which companies with increased CTGF expression. Therefore, this project assumes that fibrocyte will differentiation to fibroblast/myofibroblast in patient with acute lung injury, which in turn leads to progression of fibrosis. The central hypothesis of this project is that peripheral progenitor cell fibrocytes play an important role in alveolitis caused by acute lung injury. The overall objective of this project is to study the role of fibrocytes in acute lung injury.

Study Type

  • Study Type: Observational
  • Study Design

Participating in This Clinical Trial

Inclusion Criteria

  • Acute Lung Injury patients – Above 20 years old – Bilateral lung infiltrates – PaO2/FiO2<300mmHg – PCWP<18mmHg Exclusion Criteria:

  • Pregnant women – Under 20 years old – Hb<8.0mg/dl

Gender Eligibility: All

Minimum Age: 20 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Taipei Medical University WanFang Hospital
  • Provider of Information About this Clinical Study
    • Kuan-Jen Bai, Division of Pulmonary & Critical Care Medicine
  • Overall Official(s)
    • Kuan-Jen Bai, Principal Investigator, Taipei Medical University WanFang Hospital

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.